{
    "2018-08-06": [
        [
            {
                "time": "",
                "original_text": "【财通医药】健帆生物(300529)：中报持续高增长，销售发力，临床研究大突破",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "中报",
                        "高增长",
                        "销售发力",
                        "临床研究",
                        "大突破"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【医药丨周小刚】健帆生物(300529)：中报业绩靓丽，产品收入增长明显加快",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "中报",
                        "业绩靓丽",
                        "产品收入",
                        "增长明显加快"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}